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Objective: Case management has been widely used as an intervention in the treatment of substance
abuse problems. Its effectiveness has been associated with over 450 outcomes, some consistent with
case management’s traditional functions of linking (treatment tasks) and others typical of treatment
outcomes such as substance use (personal functioning). Method: Meta-analyses were conducted on
21 randomized clinical trials in which we compared the efficacy of case management with
standard-of-care conditions and active interventions. Characteristics of case management—
including targeted outcomes, case management model, location on the treatment continuum, and
intervention quality—were treated as moderators, as were 2 study features, length of follow-up, and
methodological quality. Results: Results showed that case management was efficacious across all
targeted outcomes when compared with standard of care (ˆ  0.15, SE  0.037), although the
overall effect was weak. There was a significant difference, F(1, 429)  25.26, p  .0001, between
case management’s effect on treatment task outcomes such as linking with and staying in treatment
(ˆ2  .29, p  .001) and improving individuals’ functioning of persons with substance abuse
problems in areas such as substance use and HIV risk behaviors (ˆ1  0.06, p  .05). Moderator
analyses demonstrated that (a) 4 case management models were more effective than standard of care
in improving treatment task outcomes and (b) case management was effective either in or out of
treatment. Conclusions: Our results demonstrate that case management is effective across a wide
range of treatment task outcomes, but more limited in its effectiveness with personal functioning
outcomes.
Keywords: case management, addiction, linkage, retention, systematic review, treatment
Case management is a ubiquitous social service intervention
implemented to assist individuals with a wide range of challenges
in accessing needed services. The core functions of case manage-
ment include assessment of major life challenges, development of
a plan of action that includes community resources, linking, and
monitoring involvement with resources and advocating on behalf
of individuals (Center for Substance Abuse Treatment, 1998; Na-
tional Association of Social Workers, 2012). Although originally
developed to assist persons with mental illness, case management
has been successfully adapted for use with persons who have
substance use disorders and significant related problems such as
poor health, substandard housing, and legal difficulties (Vander-
plasschen, Wolf, Rapp, & Broekaert, 2007). Case management has
been implemented to address multiple populations of persons with
substance abuse problems, including female welfare recipients
(Morgenstern et al., 2006; Morgenstern, Hogue, Dauber, Dasaro,
& McKay, 2009), homeless persons (Cox et al., 1998; de Vet et al.,
2013), dually diagnosed patients (Jerrell & Ridgely, 1995; Morse
et al., 2006), crack cocaine users (Rapp et al., 2008; Rapp, Siegal,
Li, & Saha, 1998), HIV-infected drug users (Sorensen et al., 2003),
and opiate-dependent persons in methadone treatment (Zanis,
McLellan, Alterman, & Cnaan, 1996). The widespread acceptance
of case management in treating substance use disorders is rein-
forced by the view that case management is an important compo-
nent of the substance abuse treatment continuum (Center for
Substance Abuse Treatment, 1998), an integral part of specific
treatment interventions (Carroll & Schottenfeld, 1997), and a
crucial component in the treatment of addictions (National Insti-
tute on Drug Abuse, 1999).
Case Management Characteristics
Although the core functions of case management remain con-
sistent, several characteristics of the intervention vary across im-
plementations. Characteristics that are frequently adapted include
targeted outcomes, practice model, and location on the continuum
of care.
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Targeted Case Management Outcomes
Case management has been expected to influence numerous
outcomes in clinical trials (Hesse, Vanderplasschen, Rapp, Broe-
kaert, & Fridell, 2007). Substance use and criminal justice involve-
ment are almost universally found among case management out-
comes, given their importance as evidence of recovery.
Assessment of the effect that case management has on substance
use outcomes is made difficult by the presence of numerous
measures recognized as indicators of substance abuse functioning
in case management trials, including widely used instruments such
as the Addiction Severity Index (McLellan et al., 1992) and the
Maudsley Addiction Profile (Marsden et al., 1998), and measures
unique to a single trial (Hesse et al., 2007). Criminal justice
involvement is somewhat easier to verify given the public nature
of court records, although here, too, self-report remains the most
common approach to assessing wrong.
Also, case management has been expected to improve out-
comes as diverse as reducing high-risk sexual and drug-using
behavior (Martin & Scarpitti, 1993; Rhodes & Gross, 1997),
enhancing quality of life (Drake et al., 1998; Karow et al.,
2010), improving living situation (Calsyn, Yonker, Lemming,
Morse, & Klinkenberg, 2005), reducing psychiatric symptoms
(Drake et al., 1998), improving occupational functioning (Cox
et al., 1998; Siegal, Fisher, Rapp, & Kelliher, 1996), enhancing
social stability (Jerrell & Ridgely, 1995b), and improving par-
enting skills (Dakof et al., 2010; Suchman et al., 2010). In
addition to these clinical outcomes, case management is widely
expected to improve treatment task outcomes such as improving
linkage rates with and retention in treatment (Mejta, Bokos,
Mickenberg, Maslar, & Senay, 1997; Scott, Sherman, Foss,
Godley, & Hristova, 2002), increasing treatment participation
and engagement, and enhancing follow-through with aftercare
services (Siegal, Rapp, Li, Saha, & Kirk, 1997).
Practice Models
Varying approaches to substance abuse case management have
included intensive (Morgenstern et al., 2006), low intensity
(Rosenheck, Neale, & Mohamed, 2010), outreach (Coviello, Za-
nis, Wesnoski, & Alterman, 2006), clinical (Downey & Braude,
2005; McLellan et al., 1999), strengths-based (Brun & Rapp,
2001; Siegal et al., 1995), brokerage (Falck, Carlson, Price, &
Turner, 1994), integrated (Halfon, Berkowitz, & Klee, 1993), and
comprehensive (Heinemann, Corrigan, & Moore, 2004). Fre-
quently, only the designation case management is used to describe
the intervention. Regardless of the specific label used to identify
case management, numerous clinical trials do not provide working
descriptions of the intervention.
Four widely recognized models, differentiated by the intensity
of services provided, include brokerage, generalist, strengths-
based, and wraparound, or Assertive Community Treatment (ACT;
Center for Substance Abuse Treatment, 1998; Vanderplasschen,
Rapp, Wolf, & Broekaert, 2004). Brokerage case management is
the least intensive model of case management, consisting of little
personal interaction between the professional providing case man-
agement services and a client. Assistance is limited to helping
clients identify their needs and passive referral, all in one or two
contacts (Stahler, Shipley, Bartelt, DuCette, & Shandler, 1995).
The opposite end of the intensity spectrum is characterized by
wraparound case management, usually in the form of ACT (Stein
& Test, 1980). ACT offers an unlimited number of contacts
between the individual substance abuser and a multidisciplinary
team of professionals (Bond, Drake, McHugo, Rapp, & Whitley,
2009). Services may be provided directly by the ACT team or by
referral to other resources. ACT case management is frequently
used with persons who have coexisting substance abuse and men-
tal health problems (Drake et al., 1998). Generalist case manage-
ment provides the traditional functions of case management—
assessment, planning, linking, monitoring, and advocacy—and is
usually characterized by a close involvement between case man-
ager and client. The structure of case management—frequency of
contacts, duration of services—may vary widely. Strengths-based
case management provides the core functions of case management
but is guided by a set of principles that emphasize assessment of
client strengths, client-driven goal setting, and assertive outreach
(Rapp, 2006). This approach is based on the view that persons who
have substance abuse problems are more likely to be successful
when they identify personal abilities and strengths rather than
deficiencies and pathology.
Role in the Continuum of Care
Case management’s implementation along the substance abuse
continuum of care is made necessary in many settings by poor
coordination and continuity of services and failure to ensure that
individuals negotiate the gap between services (Vanderplasschen
et al., 2004). Out-of-treatment opiate-dependent individuals have
frequently been the target population for case management (Corsi,
Kwiatkowski, & Booth, 2007; Coviello et al., 2006; Sorensen et
al., 2005). Persons with substance abuse problems who were
assessed but had not yet attended their first clinical appointment
have received services from case managers in centralized intake
units (Carr et al., 2008; Scott et al., 2002). In-treatment case
management has stressed retention in treatment as well as im-
provement in substance use, criminal justice involvement, and a
variety of other outcomes (Conrad et al., 1998; Cox et al., 1998;
Saleh et al., 2003). In order to maintain gains made while in
treatment, case management has also received attention as an
important part of the aftercare period (Siegal, Li, & Rapp, 2002).
Given the legal involvement of many persons with substance abuse
problems, case management has also been provided along a con-
tinuum of criminal justice interventions, from preincarceration
probation (Guydish et al., 2011) to parole for persons returning to
the community from prison (Martin & Scarpitti, 1993; Prendergast
et al., 2011).
The Current Study
The meta-analysis of substance abuse case management pre-
sented here builds on an earlier analysis published in the
Cochrane Database of Systematic Reviews that revealed case
management was significantly more effective than standard-of-
care conditions in improving outcomes (Hesse et al., 2007). In
the current study, we sought to examine that finding in more
depth by adding seven clinical trials, increasing the number of
trials from 14 to 21, and the number of targeted outcomes from
slightly over 300 to 455. Further, we addressed the issue of
whether case management has differential effects on two types
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606 RAPP ET AL.
of treatment outcomes, treatment tasks, and personal function-
ing. Moderators in this study included four characteristics of
case management—type of outcome, practice model, location
of case management on the treatment continuum, and interven-
tion quality. Two study features— duration of follow-up period
and methodological quality—were also included as moderators.
The three-level meta-analysis used in this study allowed us to
investigate the consistency of case management’s effect across
outcomes and look for the effects of moderators.
Method
Search Strategy
The search for studies of case management with persons who
have substance abuse problems was based on both electronic and
manual searches recommended by the Cochrane Drugs and Alco-
hol Group (http://cdag.cochrane.org/resources-review-authors) us-
ing the following search terms and Boolean operators: case man-
agement (OR continui care) AND addict  (OR drug [ab]use OR
drug dependen  OR substance [ab]use OR substance dependen ,
AND controlled stud  [OR controlled trial OR randomized trial
OR experimental design]). Searches included the following fields:
title, abstract, and key words of publications. Electronic searches
were conducted in the following databases from their inception
through 2012: (a) The Cochrane Central Register of Controlled
Trials (CENTRAL - The Cochrane Library, most recent), which
includes the Cochrane Drugs and Alcohol Groups specialized
register; (b) MEDLINE; (c) EMBASE; (d) CINAHL; (e) LILACS;
(f) PsycLIT; (g) Toxibase (www.toxibase.org); (h) Web of Sci-
ence; (i) PubMed; and (j) clinicaltrials.gov. In addition, manual
searches of reference lists of retrieved studies, reviews, meta-
analyses, and conference abstracts were conducted.
National focal points for drug and alcohol research, such as the
National Institute on Alcohol Abuse and Alcoholism, National
Institute on Drug Abuse, National Drug and Alcohol Research
Centre, and European Monitoring Centre for Drugs and Drug
Addiction, were contacted for information and advice concerning
past and ongoing randomized trials of case management with
substance users. Authors of studies and experts in substance abuse
and case management in various countries were contacted to find
out whether they were aware of clinical trials that assessed the
effectiveness of case management with persons who have sub-
stance use disorders. Personal contacts with authors provided the
opportunity to ask about grey literature studies, that is, studies that
were conducted but never published. There were no language or
publication year restrictions.
Selection of Clinical Trials
All abstracts and articles were reviewed independently by three
of the study authors (RR, WV, EB), all of whom have published
extensively about case management and served as experts on the
topic in the United States (RR) and Europe (WV, EB). Five criteria
were used to assess the eligibility of each clinical trial for the
meta-analyses.
• Study design had to be a clinical trial, a research design that
answers specific questions about behavioral interventions and de-
termines whether the behavioral intervention is safe, efficacious,
and effective (National Institutes of Health, 2013). Specifically, a
controlled design had to be used in the eligible clinical trials in
which participants were randomly assigned to case management
and a comparison condition. The comparison condition could be a
standard of care, active intervention, or a second case management
model.
• The entire sample had to consist of persons with substance use
disorders, either abuse or dependence. All participants could have
a drug of abuse or dependence in common or be using different
substances from other members of the sample. Studies including
people with co-occurring conditions, such as psychiatric disorders,
were eligible if it was clear that substance use disorders were
present in the entire sample.
• Descriptions and definitions of case management had to in-
clude at least four of the five basic functions commonly associated
with the intervention—assessment, planning, linking, monitoring,
and advocacy (Center for Substance Abuse Treatment, 1998; Na-
tional Association of Social Workers, 2012)—and/or the interven-
tion had to be labeled as case management by the investigators.
• Only studies in which the comparison group was a psychos-
ocial intervention were eligible. The decision to eliminate phar-
macological interventions was based on the very different mech-
anisms of action present in the two types of intervention.
• Case management was not combined with another interven-
tion and delivered together, unless it was possible to statistically
disentangle the results attributable to case management alone. An
example of a combined intervention was case management com-
bined with motivational interviewing as a single intervention;
results did not distinguish the separate effects of case management
and motivational interviewing (Karow et al., 2010).
Figure 1 provides a summary of the attrition of articles through
the selection process. One hundred thirty-five complete articles,
reports, and unpublished manuscripts were retrieved from elec-
tronic and manual searches, and unanimous agreement was
reached on the eligibility of 38 articles from 22 clinical trials (see
Table 1). Seven articles were eliminated because they did not
present results in a form where effect sizes could be calculated,
leaving 31 articles from 21 clinical trials retained for analysis.
Data Extraction and Preparation
Case management and comparison conditions. Among el-
igible trials, case management was compared with standard of care
in 18 trials and with active interventions in three. Standard of care
consisted of the usual and customary practices provided in a
treatment setting, optimally with the best practices available (Na-
tional Institutes of Health, 2013). In clinical trials, standard-of-care
conditions serve as the baseline with which to compare an exper-
imental intervention’s effects. The standard-of-care services in
meta-analysis studies varied widely in intensity, from a noninten-
sive paper referral (Coviello et al., 2006) and passive referral-HIV/
AIDS education (Sorensen et al., 2003) to more intensive exam-
ples, including community care coordination (Morgenstern et al.,
2006) and standard parole supervision and referral services (Guy-
dish et al., 2011; Prendergast et al., 2011).
In other studies, active interventions were included to assess
their effectiveness relative to case management. Active interven-
tions also varied, from motivational interviewing combined with
risk reduction strategies to extensive parenting programs (Dakof et
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607EFFICACY OF SUBSTANCE ABUSE CASE MANAGEMENT
al., 2010; Suchman et al., 2010). We retained the authors’ labels of
a comparison as standard of care or active intervention, although
the differences between the two were not always obvious.
In two of the 21 trials, case management was compared with
both a standard of care and an active intervention; motivational
interviewing in one trial (Carr et al., 2008; Rapp et al., 2008) and
treatment vouchers in another (Barnett, Masson, Sorensen, Wong,
& Hall, 2006; Sorensen et al., 2005). In two of the trials, models
of case management were compared with one another (Essock et
al., 2006; Jansson, Svikis, Breon, & Cieslak, 2005; Manuel, Cov-
ell, Jackson, & Essock, 2011).
Moderator variables. Three of the study authors (RR, WV,
EB) coded moderator variables on the basis of the criteria outlined
below.
Targeted outcomes. Four hundred fifty outcomes were present
in the 21 clinical trials. Results from the earlier Cochrane review
(Hesse et al., 2007) suggested that the effectiveness of case man-
agement varied across outcomes, possibly depending on whether
an outcome described a task of substance abuse treatment or
changes in individual functioning. From this preliminary finding,
two categories of outcomes were created, one representing treat-
ment tasks and the other personal functioning. One hundred twenty
treatment tasks outcomes were identified in five domains: linkage
with substance abuse services, retention in substance abuse ser-
vices, linkage with ancillary services, retention in ancillary ser-
vices, and satisfaction with treatment. Three hundred thirty-five
personal functioning outcomes were assigned to substance use
(alcohol and drugs), risk behaviors (drug and sex), legal/criminal
justice status, health status (mental and physical), and social in-
clusion (employment, family functioning, and housing).
Case management models. The case management model was
selected as a potential moderator to determine whether differences
in service intensity influenced effectiveness. Comparing models’
intensity was made difficult by some characteristics of the case
Arcles idenﬁed through  
database searches 
(n=125) 
Addional arcles idenﬁed 
through other sources 
(n=10)
Arcles aer duplicates removed 
(n=135) 
Arcles screened 
(n=135) 
Arcles excluded 
(n=43) 
Full-text arcles 
assessed for eligibility  
(n=92)
Full-text arcles excluded: 
(n=54) 
Study not complete (n=4)  
Not controlled trial (n = 24) 
Combined intervenons (n=14) 
Not all substance abusers (n=4) 
Not case management (n=8) 
 
Eligible arcles 
(n=38) 
Eligible arcles excluded 
because stascs not presented 
in a form that allowed 
computaon of an eﬀect size 
and corresponding standard 
errors 
(n=7) 
Eligible arcles used in 
analyses 
(n=31) 
Figure 1. PRISMA flow diagram for substance abuse case management articles (Moher, Tetzlaff, & Altman,
2009). The term article signifies published articles and reports, unpublished manuscripts, abstracts, and the like.
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management trials. Several studies provided no working definition
or description of case management. Given these difficulties, the
authors collapsed case management into four widely recognized
categories: brokerage, generalist, strengths-based, and wraparound
or ACT (Center for Substance Abuse Treatment, 1998; Vander-
plasschen, Wolf, Rapp, & Broekaert, 2007). The primary rule for
placing the case management model in a category was to follow
investigators’ explicit designation. When there was no explicit
statement about the type of case management, it was assigned to a
model on the basis of investigators’ descriptions of the interven-
tion.
Continuum location. On the basis of the participants’ status
when they were recruited into a trial, the location of case manage-
ment was identified as either in or out of treatment. The in-
treatment designation was applied whether individuals were in a
substance abuse treatment program or mental health services.
Intervention quality. None of the eligible studies included
fidelity measurements that would indicate how closely implemen-
tation of the intervention conformed to how it was designed.
Lacking this measure, we created a moderator of intervention
quality. A trial was coded as having intervention quality if an
implementation manual had been written or structured, ongoing
supervision was described. Trials that did not report having a
manual or supervision were assumed to not have these character-
istics.
Study feature moderators. Length of study follow-up was
included as a moderator to investigate whether the effect of case
management changed over time. These moments were categorized
in the following categories: 3 months, 6 months, 9 months, 12
months, 15 months, 18 months, and 24 months or more. Follow-up
periods ranged from 1 to 48 months.
Methodological quality was assessed using the Methodological
Quality Scale (Miller & Wilbourne, 2002) and included as a
moderator variable. Quality scores range from minimal quality,
“0,” to maximum quality, “24.”
Reporting and publication bias. Reporting and publication
bias are potential sources of uncertainty in any meta-analysis, as
they reflect the tendency for available research to favor interven-
tions supported by study authors (Vevea & Woods, 2005). A
reporting and publication bias emerges when statistically signifi-
cant effects are more likely to be reported and published than
nonsignificant effects, leading to an inflated overall effect size. In
case of bias, we would expect a relationship between the observed
effect sizes and the corresponding standard errors. To check for
publication and reporting bias, we used the Egger’s regression
intercept test (Egger, Smith, Schneider, & Minder, 1997). More-
over, we applied the Duval and Tweedie’s trim and fill method
(Duval & Tweedie, 2000) to make an effect estimate corrected for
publication bias. These analyses and tests were done in Compre-
hensive Meta-Analysis (CMA; Borenstein, Hedges, Higgins, &
Rothstein, 2005).
Analysis
Before being combined and compared, reported data were con-
verted to a common metric. We used the standardized mean
difference, , to express the size of effect, assuming a common
standard deviation for the case management and comparison con-
ditions. Sometimes this measure could be computed directly, in
other cases data were derived from test statistics, p values or other
effect size metrics such as odds ratio’s and correlation coefficients.
Besides estimating  for each outcome reported in a trial, we also
estimated its corresponding standard error, because these standard
errors were used in the meta-analysis to determine the weight of
each effect size and to estimate the precision of the estimates of the
parameters of our meta-analytic model (Hedges, 1981). All calcu-
lations and conversions were computed using the CMA software.
Most meta-analytic methods assume that effect sizes that are com-
bined are statistically independent. In our meta-analysis, however,
there were several sources of dependence. Ignoring these dependen-
cies would lead to flawed statistical inferences: too small standard
errors resulting in too many Type I errors (the null hypothesis is too
easily rejected) and too small confidence intervals (estimates are less
accurate than suggested by the confidence intervals) (Becker, 2000).
Therefore, we used a three-level meta-analytic model to deal with the
dependence, that is, with the overlap in information given by effect
sizes from the same study (Van den Bussche, Van den Noortgate, &
Reynvoet, 2009; Van den Noortgate, Lopez-Lopez, Marin-Martinez,
& Sanchez-Meca, 2012). In this way, estimated standard errors are
still appropriate, and power and accuracy are not artificially inflated.
This model accounts for three sources of variance: among-study
variance (systematic differences among studies in the effect over
outcomes), among-outcomes variance (systematic differences within
studies among effects for multiple outcomes), and sampling variance
(referring to deviations of the observed effect sizes from the popula-
tion effect sizes, due to the fact that in a study, only a sample of
participants was included). The advantage of the three-level approach
is that it does not require aggregating the effect sizes within the
studies, and therefore we gain insight not only in differences among
studies but also in the consistency of effect estimates within studies
and can further study a possible within-study heterogeneity by look-
ing for within-study moderator variables.
Parameters of the three-level meta-analytic models were esti-
mated, using restricted maximum likelihood estimation, imple-
mented in the mixed procedure from SAS (Littell, Milliken,
Stroup, Wolfinger, & Schabenberger, 2006). The mean and the
moderating effects were statistically tested by comparing the ratio
of the estimate over the corresponding standard error estimate to a
t distribution, with degrees of freedom estimated using the Satter-
thwaite method (Satterthwaite, 1946). A likelihood ratio test was
used for testing the (residual) heterogeneity among outcomes and
among studies (Raudenbush & Bryk, 2002).
Besides the use of a three-level model, we performed sepa-
rate analyses for clinical trials comparing case management
with a standard-of-care condition and with an active interven-
tion condition. Because only five studies were available, mod-
erator variables were not applied to comparisons of case man-
agement and active interventions.
Results
Observed effect sizes for 119 of the 120 treatment task
outcomes ranged from 0.64 to 1.93, with a median of 0.14.
One confidence interval had extremely large limits [6.09, 8.08],
which were far outside the range of the other values. This
outlier, the effect on nonsubstance abuse treatment tasks found
in Prendergast et al. (2011), was not excluded from the first
analysis, because it had little effect on the results. It was
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excluded from the moderator analyses, because we found that
this outlier had a large impact on the estimated moderator
effects. Thirty-one observed effect sizes are smaller than zero,
one equal to zero, and 87 larger than zero. Thirty observed
effect sizes are significantly larger than zero, only one signif-
icantly smaller than zero. Effect sizes of .20, .50, and .80 refer
to, respectively, small, moderate, and large effects (Cohen,
1992).
Observed effect sizes of 335 personal functioning outcomes
ranged from 2.90 to 2.19, with a median of 0.030. One hundred
thirty-two observed effect sizes were smaller than zero, 19 were
exactly equal to zero, and the remaining 184 effect sizes were
larger than zero. Only 23 observed effect sizes were significantly
larger than zero (if tested on a .05 significance level), whereas 11
effect sizes were significantly smaller than zero.
Because studies typically reported multiple outcomes for
which effect sizes could be calculated, and effect sizes from the
same study were likely to be more similar, we also summarized
the effect sizes in a forest plot with one confidence interval per
clinical trial. See Figure 2.
Case Management and Standard-of-Care Condition
In the initial three-level analysis, we included all 18 clinical
trials that contained a comparison of case management and stan-
dard of care. We found an estimate of the overall effect () equal
to 0.15, with a standard error of 0.037. This effect can be consid-
ered as small, although it is statistically significant, t(13.7) 3.97,
p  .001.
A three-level approach allowed us to assess heterogeneity
among studies, as well as heterogeneity among outcomes within
the same study. We found statistically significant variation among
studies, ˆ2  0.018, 2(1)  73.5, p  .0001, as well as among
outcomes from the same study, ˆ2  0.013, 2(1)  50.2, p 
.0001. To interpret the size of these variances, we compared them
with the size of the sampling variance, which is the variance at the
first level. Because this variance depends on the size of the study,
we looked at the median value of the estimated sampling variance,
which was equal to 0.026. This means that for typical studies,
about 32% of the total variance in observed effect sizes (0.018 
0.0134  0.026) is variance among studies, 23% variance among
Figure 2. Forest plot of the average observed effect sizes per clinical trial, with the corresponding 95%
confidence intervals (CI). Standardized differences (std diff) to the right of .00 favor case management; those to
the left of .00 favor the comparison condition. Only first authors are given when only one reference begins with
those authors. In other cases, the date clarifies the intended reference. Morgenstern refers to Morgenstern,
Hogue, et al. (2009).
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612 RAPP ET AL.
outcomes from the same study, and 45% random-sampling vari-
ance. We note that the interpretation of these measures is similar
to the interpretation of I2 used when there are only two sources of
variation: I2 refers to the percentage of variance at the study level.
The percentages suggest there were substantial differences among
outcomes and especially among studies in the size of the effect so
that the estimate of the mean effect is less informative. More
specifically, based on these estimates and on the assumption of
normality at both the study and within-study level, we expected
that 95% of the study-specific mean effects range between 0.12
and 0.41 and that for a study with an average effect of 0.15, 95%
of the investigated effects in that study range between 0.08 and
0.37. Given the size and significance of the variance at the study
and outcome level, we therefore explored how this variance can be
explained by performing moderator analyses in those studies in
which case management was compared with standard-of-care con-
ditions. Case management and standard of care: Treatment task
and personal functioning outcomes
To investigate the difference among treatment tasks and per-
sonal functioning, we defined two dummy indicator variables, one
for treatment tasks and one for personal functioning, and included
these indicators in our meta-analytic model. Seventeen clinical
trials contained treatment tasks; 13 trials contained personal func-
tioning outcomes. In this way, we estimated the overall effect for
outcomes related to treatment tasks and personal functioning and
allowed that the variance among outcomes also depends on the
kind of outcome. We assumed a common among-study variance to
make the model estimations converge. We found that at the out-
come level, case management had a moderate effect on treatment
tasks (ˆ2  .27), t(429)  5.96, p  .0001, and that its effect size
for personal functioning outcomes was very weak, although sta-
tistically significant (ˆ1  .07), t(429)  2.44, p  .02. The
difference between treatment task and personal functioning out-
comes was significant, F(1, 429)  25.26, p  .0001. Within
studies, there were large differences in effect sizes for treatment
tasks, ˆ2  0.104, but much smaller differences among outcomes
regarding personal functioning, ˆ2  0.004. The estimate of the
variance among studies, ˆ2, was equal to 0.010. Both the average
effect and the variation in effects were larger for treatment tasks.
Because of the apparent differences between the effects on treat-
ment tasks and personal functioning, we decided to continue our
analyses separately on treatment task and personal functioning
outcomes. Because the one outlying effect size can be influential
when estimating effects for specific subcategories of studies, it was
not included in the remaining analyses.
Case management and treatment tasks. When treatment
tasks were analyzed separately at the study level, the overall
treatment effect size estimate,ˆ, was equal to 0.29, t(13.7)  4.11,
p  .001. There were no longer differences among outcomes from
the same study, ˆ2  0, but relatively large differences among
studies, ˆ2  0.073, 2(1)  60.6, p  .0001, with the proportion
of the total variance that is variance at the study level equal to
65%. The upper section of Figure 2 presents the average observed
effect sizes for 17 clinical trials in which case management is
compared with standard of care on treatment task outcomes.
Moderator effects. The estimated effect for each outcome area
is presented on the left side of Figure 3. The effect of case
management was largest for retention in substance abuse treatment
(ˆ 0.36, p .0002) and smallest for linkage to ancillary services
and satisfaction with treatment (ˆ  0.26, p  .002). Linkage
effects for substance abuse treatment was ˆ  0.27, and for
ancillary services retention, it was ˆ  0.31. The differences
among effect sizes for the five outcome types were not significant,
F(4, 114)  0.84, p  .50.
We found that the effect size estimates were similar for all four
case management models and that differences among models were
statistically not significant, F(3, 15.7)  0.23, p  .88. The
estimated effect size was significant for both out-of-treatment (ˆ
0.28, p  .01) and in-treatment groups (ˆ  0.33, p  .04),
although the difference between the two treatment groups was not
statistically significant, F(1, 12)  0.13, p  .73. Moderators that
did not have a significant effect are not reported here.
Case management and personal functioning. When analyz-
ing the data regarding personal functioning separately, we found
(in line with the overall analysis) a weak average effect: ˆ1  .06,
an effect that approaches statistical significance, t(11)  2.18, p 
.06. The middle section of Figure 2 presents the average observed
effect sizes for 13 clinical trials in which case management is
compared with standard of care on personal functioning outcomes.
Moderator effects. Of the five different personal functioning
outcome areas, case management had a statistically significant
effect on social inclusion (ˆ  0.09, p  .02), substance use (ˆ 
0.08, p  .01), and risk behaviors (ˆ  0.09, p  .04). There were
significant differences among the effects for the five outcome
types, F(4, 185)  2.73, p  .03. Estimates and corresponding
95% confidence intervals are given in Figure 3.
Generalist case management was the only model for which there
is almost statistically significant evidence for an effect on personal
functioning (ˆ  .11, p  .06). ACT, the most intensive model of
case management, had an estimated effect of ˆ  .04, p  .59,
strengths-based case management, ˆ  0.03, p  .67, and broker-
age, the least intensive model, ˆ  0.07, p  .31. There were,
however, no significant differences among the four models, F(3,
12.4)  0.73, p  .57. Investigating the moderator effect of
duration of follow-up, we found that the effect of case manage-
ment was only significant at 12 months (ˆ  0.09, p  .01), but
effect estimates were similar for all follow-up periods, and there
were no statistical differences among the seven follow-up periods,
F(6, 204)  0.86, p  .52. Moderators that did not have a
significant effect are not reported here.
Case Management and Active Interventions
In total, five clinical trials contained 77 case management
comparisons with active interventions. Case management was
compared with motivational interviewing (Rapp et al., 2008),
motivational interviewing with risk reduction (Corsi et al.,
2007), vouchers to pay for treatment (Sorensen et al., 2005),
and parenting classes for women (Dakof et al., 2010; Suchman
et al., 2010). The studies contained five different outcome
domains: health status and substance use functioning and link-
age with substance abuse and ancillary services, and finally
social inclusion. The active interventions were, on average,
more effective than case management, although the effect was
weak and nonsignificant (ˆ  .08), t(7.62)  0.94, p  .38.
Average observed effect sizes for five clinical trials are pre-
sented in the lower section of Figure 2. Moderator analyses
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613EFFICACY OF SUBSTANCE ABUSE CASE MANAGEMENT
were not performed on active intervention comparisons, given
the limited number of studies.
Checking model assumptions. Egger’s intercept test (Egger
et al., 1997) did not reveal evidence for reporting or publication
bias, t(15)  1.20, p  .25, for treatment tasks outcomes and,
t(11)  0.17, p  .87, for personal functioning. Correcting the
estimated effects for publication bias using the Duval and Tweedie
(2000) trim and fill method results in a decrease of the estimated
effect from 0.37 to 0.31, with a 95% confidence interval between
0.11 and 0.51 for treatment-related outcomes, and no change for
personal functioning. To check the assumption that the residuals
are normally distributed, we made normal quantile plots (not
shown in this article). There was no evidence for nonnormality in
any of the analyses.
We performed sensitivity analyses, checking the impact of in-
dividual studies on the results by reanalyzing the data without
moderators, each time leaving out one study. We found that the
impact was small: For the treatment tasks, the estimated mean
effect varied from 0.23 (p  .001; when leaving out Rapp et al.,
1998) to .31 (p  .001; when leaving out the clinical trial of
Rhodes & Gross, 1997). For personal functioning, the impact on
the estimates was also small, but whether the mean effect was
statistically significant depended on what study was left out: The
estimated mean effect varies from 0.049 (p  .11; without the
Morgenstern clinical trial) to 0.08 (p  .03; without the trial of
Sorensen et al., 2003). For the comparison of case management
with active interventions, effect size estimates ranged be-
tween 0.12 (p  .26; without the Corsi et al., 2007 trial) and
0.023 (p  .19; without the trial of Sorensen et al., 2005).
Discussion
In this study, we examined the effects of case management on
outcomes associated with substance abuse treatment. In the current
study, seven clinical trials and over 150 new outcomes were added
to a previous Cochrane Collaboration meta-analysis (Hesse et al.,
2007). We also sought to identify in the current study whether or
not case management had differential effects on treatment task and
personal functioning outcomes. The three-level meta-analysis used
in this study allowed us to investigate the consistency of case
management’s effect across these outcomes and to examine the
effects of moderators (Van den Noortgate et al., 2012). Our find-
ings inform the critical question of case management’s appropriate
role in substance abuse treatment and the direction of future
research.
Case Management: Standard of Care and
Active Interventions
The primary results from the earlier study (Hesse et al., 2007)
were supported: Case management was more effective than
standard-of-care conditions in improving outcomes. Although this
finding suggests a positive role for case management, the presence
of over 450 outcomes makes the result difficult to interpret be-
cause the outcomes are extremely diverse, including reducing HIV
risk behavior, improving parenting skills, and facilitating linkage
with treatment. Such broad expectations of a single intervention
appear to be unfounded, as it is unlikely that any single psychos-
ocial intervention can be expected to affect so many different
outcomes. In some trials, the standard-of-care conditions included
intensive services further obscuring the assessment of case man-
agement’s effectiveness. The fact that case management had a
significant effect on treatment task outcomes, even though some of
the comparisons were relatively intensive, suggests that the re-
ported effect size was conservative (i.e., it likely would have been
larger if the comparison conditions had all been low intensity).
Although active interventions were more effective than case man-
agement, the effect was very weak and nonsignificant. The finding
should be viewed with caution because only five clinical trials in-
cluded a researcher-designated intervention, and the outcomes varied
Figure 3. Forest plot of estimated effect sizes by individual (left) and combined (right) outcomes. AS 
ancillary services; SA  substance abuse.
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widely, including vouchers for treatment, motivational interviewing,
and two comprehensive parenting programs for women.
Case Management: Treatment Tasks and Personal
Functioning Outcomes
Using a three-level approach, we identified a clinically impor-
tant difference in how case management impacts treatment tasks
compared with personal functioning outcomes. When treatment
task and personal functioning outcomes were analyzed separately,
we found case management’s effect on the two groups was sig-
nificantly different, moderate for treatment tasks, and minimal for
personal functioning. Effect sizes for all five groups of treatment
tasks—retention in ancillary and substance abuse services, treat-
ment satisfaction, and linkage in ancillary and substance abuse
services—were considerably larger than the highest personal func-
tioning areas, risk behaviors and social inclusion. This finding is
consistent with the results of meta-analyses of case management
with mental health populations (Oldham, Kellett, Miles, &
Sheeran, 2012; Ziguras & Stuart, 2000).
The finding that case management benefits treatment tasks was
not surprising given the primary purpose of case management: to
help individuals identify needed services, select the most appro-
priate services available in a given geographical area, facilitate
linkage with services and promote continued retention in services
by monitoring individuals’ participation, coordinate the activities
of multiple services when present and when necessary, and advo-
cate for continued participation (National Association of Social
Workers, 2012). Case management was equally effective in im-
proving treatment task outcomes whether they involved substance
abuse treatment or ancillary services. The implications of these
findings are clear; if persons with substance abuse problems do not
link with and remain in care, especially with substance abuse
treatment, they cannot benefit from treatment interventions de-
signed to improve functioning, no matter how effective the inter-
ventions themselves may be.
Our meta-analyses did not reveal an association between case
management and personal functioning outcomes. Findings from
previous studies suggest two alternative ways in which functioning
may be impacted by case management. First, it is possible that case
management has an indirect effect on personal functioning out-
comes, through its effect on treatment tasks, if case management
links individuals with and engages them in effective treatments.
For example, persons with substance abuse problems who were
leaving residential treatment and recently released parolees, both
of whom were receiving case management, were retained in treat-
ment longer than individuals not receiving case management. The
longer retention was associated with a reduction in substance use
at 6 months follow-up (Guydish et al., 2011; Rapp et al., 1998) and
reduced criminal justice involvement at 12 months (Siegal et al.,
2002). It appears that improved functioning was not a direct effect
of case management, but a result of its ability to improve retention.
Second, by combining case management functions with special-
ized skills, personal functioning outcomes may be improved. An
example of specialized training for case managers can be found in
clinical case management where a single professional is trained to
offer a regimen of therapeutic support and case management
functions (Downey & Braude, 2005). In this instance, expecting
case management to improve a personal functioning outcome such
as reduction in psychiatric symptoms may be appropriate. It may
also be possible to combine case management functions with other
interventions such as risk reduction activities. The expanded role
of case management has been a frequent part of case management
for persons with mental health and HIV/AIDS problems (Drake et
al., 1998; Morse et al., 2006).
Moderator effects on treatment tasks. We expected that
ACT would have a substantially stronger effect on treatment task
outcomes than other models, particularly brokerage case manage-
ment. We also expected that generalist case management would
provide an effect that was stronger than brokerage, but less than
strengths-based case management. These predictions were based
on the fact that brokerage case management usually consists of
brief referral with little or no follow-up, whereas ACT services are
provided as part of a highly integrated team who can address client
needs intensively and by referral to outside sources (Rosen,
Mueser, & Teesson, 2007; Ziguras & Stuart, 2000). We also
anticipated that the emphasis on strengths and assets of strengths-
based case management would provide a value-added benefit over
and above the basic functions of generalist case management.
Although all results were in the expected direction, the differences
among models’ effect sizes were not significantly different. The
finding that ACT was not substantially more effective than bro-
kerage case management may have been population-related; two
of the three ACT trials consisted of dually diagnosed individuals,
ostensibly a group with greater impairment. This issue needs to be
examined further, given the much higher costs involved in imple-
menting ACT (Jerrell & Hu, 1996). Although these results may
accurately reflect the similarity of the four models in improving
treatment task outcomes, there are also limitations in the trials that
we reviewed that could have affected results. There were only two
studies of brokerage case management and five of ACT available
for analysis, and the relatively small number of participants in
these studies may have affected results. Second, the frequently
vague or absent descriptions of case management accompanying
the studies may have resulted in our inaccurately categorizing the
models in some studies.
A second moderator finding showed that case management im-
proved treatment task outcomes for persons in treatment when case
management began, as well as those who were out of treatment. The
benefit of case management to persons who were out of treatment was
in facilitating linkage with treatment and was demonstrated in several
settings (Morgenstern et al., 2006; Rapp et al., 2008; Scott et al., 2002;
Sorensen et al., 2005). Case management’s primary benefit to in-
treatment populations was to improve retention (Siegal et al., 2002).
The importance of both linkage and retention cannot be overstated,
given the consistent association between retention and treatment suc-
cess (Vanderplasschen et al., 2013).
Neither of the study features used as moderators—length of
study follow-up or methodological quality—demonstrated signif-
icant effects on the effectiveness of case management.
Limitations of the Review
This meta-analytic review has limitations that are often cited as
endemic to all meta-analyses (Lipsey & Wilson, 2001; Sharpe,
1997). First, all studies selected for inclusion in the meta-analysis
were randomized trials. Quasi-experimental trials may be another
source for case management studies. Even though the trials in this
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study were all randomized, they still differed methodologically. As
an example, studies used numerous different instruments to mea-
sure personal functioning outcomes, at least 10 to measure sub-
stance use. Also, the trials in this analysis contained at least seven
fairly distinct populations, including persons with both substance
abuse and mental health problems, women probationers, injectable
drug users with and without HIV, and homeless men, among
others. It is likely that members of these groups have different
treatment needs, which may also affect goals and objectives ad-
dressed by case managers.
Another limitation of the meta-analysis was the result of the
total absence of fidelity measures to assess the clinical quality of
the case management that was delivered in a trial. A lack of fidelity
measures kept us from determining whether or not a model’s
implementation was robust or marginal and then controlling for
that difference through moderator analyses.
Even though we used characteristics of case management as
moderators to help explain its efficacy, it is difficult to quantify all
of the influences that might influence outcomes. Case management
is frequently described as being contextual and reflective of the
setting in which it is located (Rapp et al., 2008; Vanderplasschen
et al., 2004), suggesting that the availability of community services
may influence the overall success of case management and the
specific model that is optimal in a given situation. Even when
resources are available, the quality of care is likely beyond the
control of case managers.
Conclusions
Case management used in the treatment of substance use disor-
ders was moderately effective in improving linkage and retention
with substance abuse treatment and important ancillary services.
This finding alone suggests that the functions of case management
should be fully integrated into the substance abuse continuum of
care and into new treatment interventions. Future studies that
clarify case management’s mechanism of action in enhancing
treatment tasks will be important. If case management is expected
to improve personal functioning outcomes, selected behavior
change strategies should be blended with traditional case manage-
ment functions.
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